Hospital Universitario de Rio Hortega

Valladolid 47012

2 studies enrolling now · 3 studies all time

What they study most

Agitation, Alzheimer Disease, Hepatocellular Carcinoma, Hepatocellular Carcinoma Surveillance

Studies at this site

• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now
• Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed